Recent developments in biosensors for healthcare and biomedical applications: A review
The development of biosensors is gaining tremendous attention in the fields of biomedicine
and healthcare due to their wide use in clinical care, medicine and food processing …
and healthcare due to their wide use in clinical care, medicine and food processing …
Smart wearable body sensors for patient self-assessment and monitoring
G Appelboom, E Camacho, ME Abraham… - Archives of public …, 2014 - Springer
Background Innovations in mobile and electronic healthcare are revolutionizing the
involvement of both doctors and patients in the modern healthcare system by extending the …
involvement of both doctors and patients in the modern healthcare system by extending the …
ISPAD clinical practice consensus guidelines 2022: diabetes technologies: glucose monitoring
M Tauschmann, G Forlenza, K Hood… - Pediatric …, 2022 - Wiley Online Library
Self-monitoring of glucose has a pivotal role in the management of insulin-treated children
and adolescents with diabetes. It tracks immediate and daily glucose levels including …
and adolescents with diabetes. It tracks immediate and daily glucose levels including …
Glucose outcomes with the in-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes
SK Garg, SA Weinzimer, WV Tamborlane… - Diabetes technology …, 2017 - liebertpub.com
Background: The safety and effectiveness of the in-home use of a hybrid closed-loop (HCL)
system that automatically increases, decreases, and suspends insulin delivery in response …
system that automatically increases, decreases, and suspends insulin delivery in response …
Home use of an artificial beta cell in type 1 diabetes
H Thabit, M Tauschmann, JM Allen… - … England Journal of …, 2015 - Mass Medical Soc
Background The feasibility, safety, and efficacy of prolonged use of an artificial beta cell
(closed-loop insulin-delivery system) in the home setting have not been established …
(closed-loop insulin-delivery system) in the home setting have not been established …
[PDF][PDF] ISPAD clinical practice consensus guidelines 2018: diabetes technologies
JL Sherr, M Tauschmann, T Battelino, M de Bock… - Pediatr Diabetes, 2018 - bnsde.org
ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes technologies Page 1 ISPAD
CLINICAL PRACTICE CONSENSUS GUIDELINES ISPAD Clinical Practice Consensus …
CLINICAL PRACTICE CONSENSUS GUIDELINES ISPAD Clinical Practice Consensus …
Outpatient glycemic control with a bionic pancreas in type 1 diabetes
SJ Russell, FH El-Khatib, M Sinha… - … England Journal of …, 2014 - Mass Medical Soc
Background The safety and effectiveness of automated glycemic management have not
been tested in multiday studies under unrestricted outpatient conditions. Methods In two …
been tested in multiday studies under unrestricted outpatient conditions. Methods In two …
Closed-loop artificial pancreas systems: engineering the algorithms
In this two-part Bench to Clinic narrative, recent advances in both the preclinical and clinical
aspects of artificial pancreas (AP) development are described. In the preceding Bench …
aspects of artificial pancreas (AP) development are described. In the preceding Bench …
Closed-loop insulin delivery during pregnancy in women with type 1 diabetes
ZA Stewart, ME Wilinska, S Hartnell… - … England Journal of …, 2016 - Mass Medical Soc
Background In patients with type 1 diabetes who are not pregnant, closed-loop (automated)
insulin delivery can provide better glycemic control than sensor-augmented pump therapy …
insulin delivery can provide better glycemic control than sensor-augmented pump therapy …
[HTML][HTML] Current advances of artificial pancreas systems: a comprehensive review of the clinical evidence
SJ Moon, I Jung, CY Park - Diabetes & Metabolism Journal, 2021 - synapse.koreamed.org
Abstract Since Banting and Best isolated insulin in the 1920s, dramatic progress has been
made in the treatment of type 1 diabetes mellitus (T1DM). However, dose titration and timely …
made in the treatment of type 1 diabetes mellitus (T1DM). However, dose titration and timely …